| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.04 |